Functional Profiling of Precursor MicroRNAs Identifies MicroRNAs Essential for Glioma Proliferation

PLoS ONE

Volumn 8, Issue 4, 2013, Pages

  Haapa Paananen, Saija ^a   Chen, Ping ^b   Hellström, Kirsi ^a   Kohonen, Pekka ^a   Hautaniemi, Sampsa ^b   Kallioniemi, Olli ^a,b   Perälä, Merja ^a  

^a VTT TECHNICAL RESEARCH CENTRE OF FINLAND   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; MICRORNA 129; MICRORNA 136; MICRORNA 145; MICRORNA 155; MICRORNA 181B; MICRORNA 342; MICRORNA 376A; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; ASTROCYTE; CANCER CELL; CANCER GROWTH; CANCER SURVIVAL; CARCINOGENESIS; CELL PROLIFERATION; CONTROLLED STUDY; CSF1R GENE; EIF2AK1 GENE; FGF7 GENE; GENE EXPRESSION PROFILING; GENE FUNCTION; GENE TARGETING; GLIOBLASTOMA; HUMAN; HUMAN CELL; IN VIVO STUDY; MET GENE; ONCOGENE; RHOA GENE; ROCK1 GENE; TUMOR SUPPRESSOR GENE;

CELL PROLIFERATION; GENE EXPRESSION PROFILING; GLIOBLASTOMA; HUMANS; MICRORNAS; NEOPLASTIC CELLS, CIRCULATING;

EID: 84875940715     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0060930     Document Type: Article

References (34)

1. Lagos-Quintana M, Rauhut R, Meyer J, Borkhardt A, Tuschl T, (2003) New microRNAs from mouse and human. RNA 9: 175-179.
2. Kasinski AL, Slack FJ, (2011) Epigenetics and genetics. MicroRNAs en route to the clinic: Progress in validating and targeting microRNAs for cancer therapy. Nat Rev Cancer 11: 849-864 doi:10.1038/nrc3166.
3. Nana-Sinkam SP, Croce CM, (2011) Non-coding RNAs in cancer initiation and progression and as novel biomarkers. Mol Oncol 5: 483-491 doi:10.1016/j.molonc.2011.10.003.
4. Esquela-Kerscher A, Slack FJ, (2006) Oncomirs- microRNAs with a role in cancer. Nat Rev Cancer 6: 259-269 doi:10.1038/nrc1840.
5. DeSano JT, Xu L, (2009) MicroRNA regulation of cancer stem cells and therapeutic implications. AAPS J 11: 682-692 doi:10.1208/s12248-009-9147-7.
6. Davis FG, McCarthy BJ, (2001) Current epidemiological trends and surveillance issues in brain tumors. Expert Rev Anticancer Ther 1: 395-401 doi:10.1586/14737140.1.3.395.
7. Ciafre SA, Galardi S, Mangiola A, Ferracin M, Liu CG, et al. (2005) Extensive modulation of a set of microRNAs in primary glioblastoma. Biochem Biophys Res Commun 334: 1351-1358 doi:10.1016/j.bbrc.2005.07.030.
8. Conti A, Aguennouz M, La Torre D, Tomasello C, Cardali S, et al. (2009) miR-21 and 221 upregulation and miR-181b downregulation in human grade II-IV astrocytic tumors. J Neurooncol 93: 325-332 doi:10.1007/s11060-009-9797-4.
9. Huber W, von Heydebreck A, Sultmann H, Poustka A, Vingron M, (2002) Variance stabilization applied to microarray data calibration and to the quantification of differential expression. Bioinformatics 18 (Suppl 1): S96-104.
10. Saeed AI, Sharov V, White J, Li J, Liang W, et al. (2003) TM4: A free, open-source system for microarray data management and analysis. BioTechniques 34: 374-378.
11. Saeed AI, Bhagabati NK, Braisted JC, Liang W, Sharov V, et al. (2006) TM4 microarray software suite. Methods Enzymol 411: 134-193 doi:10.1016/S0076-6879(06)11009-5.
12. Ovaska K, Laakso M, Haapa-Paananen S, Louhimo R, Chen P, et al. (2010) Large-scale data integration framework provides a comprehensive view on glioblastoma multiforme. Genome Med 2: 65 doi:10.1186/gm186.
13. Chen P, Lepikhova T, Hu Y, Monni O, Hautaniemi S, (2011) Comprehensive exon array data processing method for quantitative analysis of alternative spliced variants. Nucleic Acids Res 39: e123 doi:10.1093/nar/gkr513.
14. Cancer Genome Atlas Research Network, (2008) Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature 455: 1061-1068 doi:10.1038/nature07385.
15. Noushmehr H, Weisenberger DJ, Diefes K, Phillips HS, Pujara K, et al. (2010) Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma. Cancer Cell 17: 510-522 doi:10.1016/j.ccr.2010.03.017.
16. Verhaak RG, Hoadley KA, Purdom E, Wang V, Qi Y, et al. (2010) Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1. Cancer Cell 17: 98-110 doi:10.1016/j.ccr.2009.12.020.
17. Selbach M, Schwanhausser B, Thierfelder N, Fang Z, Khanin R, et al. (2008) Widespread changes in protein synthesis induced by microRNAs. Nature 455: 58-63 doi:10.1038/nature07228.
18. Papadopoulos GL, Reczko M, Simossis VA, Sethupathy P, Hatzigeorgiou AG, (2009) The database of experimentally supported targets: A functional update of TarBase. Nucleic Acids Res 37: D155-8 doi:10.1093/nar/gkn809.
19. Gibcus JH, Tan LP, Harms G, Schakel RN, de Jong D, et al. (2009) Hodgkin lymphoma cell lines are characterized by a specific miRNA expression profile. Neoplasia 11: 167-176.
20. Kong W, Yang H, He L, Zhao JJ, Coppola D, et al. (2008) MicroRNA-155 is regulated by the transforming growth factor beta/Smad pathway and contributes to epithelial cell plasticity by targeting RhoA. Mol Cell Biol 28: 6773-6784 doi:10.1128/MCB.00941-08.
21. Lu C, Huang X, Zhang X, Roensch K, Cao Q, et al. (2011) miR-221 and miR-155 regulate human dendritic cell development, apoptosis, and IL-12 production through targeting of p27kip1, KPC1, and SOCS-1. Blood 117: 4293-4303 doi:10.1182/blood-2010-12-322503.
22. Zhi F, Chen X, Wang S, Xia X, Shi Y, et al. (2010) The use of hsa-miR-21, hsa-miR-181b and hsa-miR-106a as prognostic indicators of astrocytoma. Eur J Cancer 46: 1640-1649 doi:10.1016/j.ejca.2010.02.003.
23. Shi L, Cheng Z, Zhang J, Li R, Zhao P, et al. (2008) Hsa-mir-181a and hsa-mir-181b function as tumor suppressors in human glioma cells. Brain Res 1236: 185-193 doi:10.1016/j.brainres.2008.07.085.
24. Chen JJ, London IM, (1995) Regulation of protein synthesis by heme-regulated eIF-2 alpha kinase. Trends Biochem Sci 20: 105-108.
25. Kulkarni AP, Mittal SP, Devasagayam TP, Pal JK, (2009) Oxidative stress perturbs cell proliferation in human K562 cells by modulating protein synthesis and cell cycle. Free Radic Res 43: 1090-1100 doi:10.1080/10715760903179673.
26. Cittelly DM, Das PM, Spoelstra NS, Edgerton SM, Richer JK, et al. (2010) Downregulation of miR-342 is associated with tamoxifen resistant breast tumors. Mol Cancer 9: 317 doi:10.1186/1476-4598-9-317.
27. Xu N, Papagiannakopoulos T, Pan G, Thomson JA, Kosik KS, (2009) MicroRNA-145 regulates OCT4, SOX2, and KLF4 and represses pluripotency in human embryonic stem cells. Cell 137: 647-658 doi:10.1016/j.cell.2009.02.038.
28. Fang X, Yoon JG, Li L, Yu W, Shao J, et al. (2011) The SOX2 response program in glioblastoma multiforme: An integrated ChIP-seq, expression microarray, and microRNA analysis. BMC Genomics 12: 11 doi:10.1186/1471-2164-12-11.
29. Zohrabian VM, Forzani B, Chau Z, Murali R, Jhanwar-Uniyal M, (2009) Rho/ROCK and MAPK signaling pathways are involved in glioblastoma cell migration and proliferation. Anticancer Res 29: 119-123.
30. Faraoni I, Antonetti FR, Cardone J, Bonmassar E, (2009) miR-155 gene: A typical multifunctional microRNA. Biochim Biophys Acta 1792: 497-505 doi:10.1016/j.bbadis.2009.02.013.
31. Tili E, Croce CM, Michaille JJ, (2009) miR-155: On the crosstalk between inflammation and cancer. Int Rev Immunol 28: 264-284 doi:10.1080/08830180903093796.
32. D'Urso PI, D'Urso OF, Storelli C, Mallardo M, Gianfreda CD, et al. (2012) miR-155 is up-regulated in primary and secondary glioblastoma and promotes tumour growth by inhibiting GABA receptors. Int J Oncol 41: 228-234 doi:10.3892/ijo.2012.1420.
33. Garnett MJ, Edelman EJ, Heidorn SJ, Greenman CD, Dastur A, et al. (2012) Systematic identification of genomic markers of drug sensitivity in cancer cells. Nature 483: 570-575 doi:10.1038/nature11005.
34. Barretina J, Caponigro G, Stransky N, Venkatesan K, Margolin AA, et al. (2012) The cancer cell line encyclopedia enables predictive modelling of anticancer drug sensitivity. Nature 483: 603-607 doi:10.1038/nature11003.